Senores Pharmaceuticals IPO Opens on December 20: Price Band, Lot Size, and Key Details You Need to Know
The much-awaited IPO of Senores Pharmaceuticals is set to open for bidding on December 20, 2024, offering investors a unique opportunity to be part of a leading pharmaceutical company. With a price band ranging from Rs 372 to Rs 391 per share, Senores Pharmaceuticals aims to raise significant capital through a combination of a fresh issue and an offer-for-sale (OFS).
What You Should Know About Senores Pharmaceuticals IPO:
- IPO Opening Date: December 20, 2024
- IPO Closing Date: December 24, 2024
- Price Band: Rs 372 - Rs 391 per share
- Lot Size: Minimum 38 shares, with multiples thereafter
Senores Pharmaceuticals, founded in December 2017, is an Ahmedabad-based company that specializes in manufacturing pharmaceutical products for regulated markets like the US, Canada, and the UK. The company also serves emerging markets and operates three dedicated R&D facilities in India and the US.
The IPO Structure:
- The IPO consists of a fresh issue of Rs 500 crore and an offer-for-sale of up to 21,00,000 equity shares by its promoters and existing shareholders.
- At the higher end of the price band, the total funds raised could reach Rs 582.11 crore.
- 75% of the net offer is reserved for Qualified Institutional Bidders (QIBs), 15% for Non-Institutional Investors (NIIs), and 10% for Retail Investors.
Utilization of Funds:
The proceeds from the fresh issue will be utilized for:
- Investment in subsidiaries
- Repayment of borrowings
- Funding working capital requirements
- Strategic acquisitions and general corporate purposes.
Key Financials:
- Net Profit (H1 FY24): Rs 23.94 crore
- Revenue (H1 FY24): Rs 183.35 crore
- Net Profit (FY23): Rs 32.71 crore
- Revenue (FY23): Rs 217.34 crore
Key Highlights:
- Anchor Book Open: December 19, 2024
- Listing Date: December 30, 2024
- Lead Managers: Equirus Capital, Ambit, Nuvama Wealth Management
- Registrar: Link Intime India
Senores Pharmaceuticals is actively expanding its product portfolio, having launched 55 products in key therapeutic areas like antibiotics and antifungal treatments, and is present in 43 countries. This IPO presents a promising investment opportunity for both seasoned investors and those looking to enter the pharmaceutical sector.
If you're looking to invest in a company with strong growth potential in the global pharmaceutical market, the Senores Pharmaceuticals IPO could be your next big move!
Reference from:-https://www.businesstoday.in/markets/ipo-corner/story/senores-pharma-ipos-opens-on-december-20-check-price-band-lot-size-more-details-457778-2024-12-18